首页 | 本学科首页   官方微博 | 高级检索  
     


Phase I study of bortezomib combined with chemotherapy in children with relapsed childhood acute lymphoblastic leukemia (ALL): A report from the therapeutic advances in childhood leukemia (TACL) consortium
Authors:Yoav Messinger MD  Paul Gaynon MD  Elizabeth Raetz MD  Raymond Hutchinson MS  MD  Steven DuBois MD  Julia Glade‐Bender MD  Richard Sposto PhD  Jeannette van der Giessen BA  Elena Eckroth CCRC  Bruce C. Bostrom MD
Affiliation:1. Pediatric Hematology and Oncology, Children's Hospitals and Clinics of Minnesota, St. Paul, Minnesota;2. Division of Hematology/Oncology, University of Southern California, Los Angeles, California;3. Department of Pediatrics, New York University School of Medicine, New York, New York;4. University of Michigan Medical School, Ann Arbor, Michigan;5. Department of Pediatrics, UCSF School of Medicine, San Francisco, California;6. Pediatric Oncology, Columbia University, New York, New York;7. Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California;8. Pediatric Hematology and Oncology, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota
Abstract:
Keywords:ALL relapse  bortezomib  chemotherapy  phase I study
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号